drugset / Trial / NCT00905047
Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer
RandomizedCrossoverOpen-labelTreatment
Summary
The scope of the trial is to determine the preference of patients, after randomization and cross-over, for one of the two treatments. Another objective of the trial is to assess and compare the safety of each treatment.
Timeline
- Start
- 2005-11-14
- Primary completion
- 2010-06
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 2500 mg/m2 | — |
| Subject | Leucovorin | Small molecule | 75 mg | — |
| Subject | tegafur-uracil | Small molecule | 300 mg/m2 | — |